NLRP3 and central nervous system cancer: To investigate NLRC4 and NLRP3 inflammasomes as potential prognostic markers in glioma patients, we compared NLRP3 (Fig. 2a) or NLRC4 (Fig. 2b) expression with survival using TCGA data.